Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host. (Q36193963)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host. |
scientific article |
Statements
Ex vivo interleukin-12-priming during CD8(+) T cell activation dramatically improves adoptive T cell transfer antitumor efficacy in a lymphodepleted host (English)
Mark P Rubinstein
Colleen A Cloud
Tracy E Garrett
Caitlin J Moore
Kristina M Schwartz
C Bryce Johnson
David H Craig
Chrystal M Paulos
22 February 2012
700-7; discussion 707-8
1 reference
1 reference
1 reference